US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X Aging Population ETF

36.22

+0.35771.00%

Post-market: 36.16-0.0550-0.15%19:30 EDT

Volume:3K

Turnover:90.56K

Market Cap:88.01M

PE:- -

High:36.23

Open:36.18

Low:35.96

Close:35.86

52wk High:39.48

52wk Low:33.59

Shares:2.43M

Float Shares:2.43M

Volume Ratio:0.36

T/O Rate:0.10%

Dividend:0.33

Dividend Rate:0.91%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Genmab at 3-Year High After Blood Cancer Drug Combination Study Results

JPMorgan Unfazed by Rising Rates Impact on China Healthcare, Remains Bullish on Biotech and CXO

Ventas (VTR) Stock Could Be Undervalued Following Its 118% Three Year Run

Simply Wall St.

Tianjin Unveils Sweeping Plan to Reshape Elderly Care and Senior Services for the Next Five Years

Edwards Lifesciences Corp. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

AbbVie Cuts Q3 Adjusted Diluted EPS Outlook to $3.73-$3.77 After $216 Million Acquired Ipr&d, Milestones Expense

Abbvie - Full-Year 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $13.76-$13.96 - SEC Filing

THOMSON REUTERS

Abbvie - Q3 2026 Gaap and Adj Earnings Include $216 Mln Bought Ipr&D and Milestones Expense - SEC Filing

THOMSON REUTERS

Abbvie Inc. Fy2026 Shr View $14.02

THOMSON REUTERS

Abbvie - Q3 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $3.73-$3.77 - SEC Filing

THOMSON REUTERS

Genmab, AbbVie Say New Drug Combo Helps Lymphoma Patients Stay Cancer-Free Longer

MT Newswires Live

Genmab and AbbVie Report Landmark Phase 3 Win for Epcoritamab Combo in Frontline DLBCL

AbbVie Blood Cancer Drug Combo Cuts Risk of Progression or Death in Late-Stage Study

Genmab, AbbVie report epcoritamab combination demonstrates improved PFS in study

Genmab Says Phase 3 Epcore DLBCL-2 Trial Shows Epcoritamab Plus R-CHOP Cuts Progression or Death Risk 51% in Newly Diagnosed DLBCL

Genmab - Phase 3 Trial Shows 51% Reduction in Risk of Progression or Death in Dlbcl

THOMSON REUTERS

Genmab: Safety Profile of Epcoritamab When Administered in Combination with Standard of Care R-Chop was Generally Well Tolerated

THOMSON REUTERS

Genmab and Abbvie Announce Epcoritamab in Combination with R-Chop Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

THOMSON REUTERS

Eli Lilly Stock (LLY) Gains on Regulatory Win for Experimental Cancer Drug

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/AGNG/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AGNG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGNG\",,,,,undefined,":{"symbol":"AGNG","market":"US","secType":"STK","nameCN":"Global X Aging Population ETF","latestPrice":36.215,"timestamp":1791576000000,"preClose":35.8573,"halted":0,"volume":2505,"hourTrading":{"tag":"盘后","latestPrice":36.16,"preClose":36.215,"latestTime":"19:30 EDT","volume":8,"amount":289.94,"timestamp":1791588605646,"change":-0.055,"changeRate":-0.001519,"amplitude":0},"delay":0,"changeRate":0.009975653493152057,"floatShares":2430258,"shares":2430258,"eps":0,"marketStatus":"Market Closed","change":0.3577,"latestTime":"10-09 16:00:00 EDT","open":36.18,"high":36.225,"low":35.963,"amount":90563.14977,"amplitude":0.007307,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":35.8573,"sharesOutstanding":2330000,"nav":35.8,"aum":86995285.17,"dividendRate":0.009071,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":36.16,"preClose":36.215,"latestTime":"19:30 EDT","volume":8,"amount":289.94,"timestamp":1791588605646,"change":-0.055,"changeRate":-0.001519,"amplitude":0},"volumeRatio":0.3576323453829022,"impliedVol":0.2783,"impliedVolPercentile":0.6454},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGNG\",,,,,undefined,":{"symbol":"AGNG","floatShares":2430258,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3576323453829022,"shares":2430258,"dividePrice":0.3285,"high":36.225,"amplitude":0.007307,"preClose":35.8573,"low":35.963,"week52Low":33.59,"pbRate":"--","week52High":39.48,"institutionHeld":0,"latestPrice":36.215,"eps":0,"divideRate":0.009071,"volume":2505,"delay":0,"ttmEps":0,"open":36.18,"prevYearClose":35.8964,"prevWeekClose":35.9447,"prevMonthClose":36.6113,"prevQuarterClose":36.6113,"fiveDayClose":35.9447,"twentyDayClose":36.5894,"sixtyDayClose":36.8312},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGNG\",params:#limit:5,,,undefined,":[{"date":"2026-06-29","symbol":"AGNG","amount":0.155552,"announcedDate":"2026-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-29","defaultRemindTime":1782739800000,"name":"Global X Aging Population ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-06-29","currency":"USD","dateTimestamp":1782705600000,"payDate":"2026-07-07"},{"date":"2025-12-30","symbol":"AGNG","amount":0.172198,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Aging Population ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"date":"2025-06-27","symbol":"AGNG","amount":0.14218,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Aging Population ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"date":"2024-12-30","symbol":"AGNG","amount":0.14617,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"Global X Aging Population ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-07","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2025-01-07"},{"date":"2024-06-27","symbol":"AGNG","amount":0.10429,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-27","defaultRemindTime":1719495000000,"name":"Global X Aging Population ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-27","currency":"USD","dateTimestamp":1719460800000,"payDate":"2024-07-05"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGNG\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-06","value":0.161273,"currency":"USD"},{"executeDate":"2021-06-29","recordDate":"2021-06-30","paymentDate":"2021-07-08","value":0.034042,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.174268,"currency":"USD"},{"executeDate":"2022-06-29","recordDate":"2022-06-30","paymentDate":"2022-07-08","value":0.107236,"currency":"USD"},{"executeDate":"2022-12-29","recordDate":"2022-12-30","paymentDate":"2023-01-09","value":0.021742,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGNG\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGNG\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673103450","title":"Genmab at 3-Year High After Blood Cancer Drug Combination Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2673103450","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673103450?lang=en_us&edition=fundamental","pubTime":"2026-10-06 15:18","pubTimestamp":1791271123,"startTime":"0","endTime":"0","summary":"BUZZ-Genmab at 3-year high after blood cancer drug combination study results** Shares in GenmabGMAB.COrise around 8%to their highest in three years, hitting top of STOXX 600.STOXXindex** Genmab and Ab","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nL8N45S0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509010.AUD","MEDX","LU2357305700.SGD","LU1934455863.HKD","LU1244550494.USD","FHLC","FTXH","IE00B19Z3581.USD","LU1929549753.HKD","LU1732800096.USD","IXJ","XLV","IE00B42XCP33.USD","LU0456855351.SGD","LU0795875086.SGD","LU1732799900.SGD","IYH","LU1003077747.HKD","LU0708994859.HKD","LU0912757837.SGD","RXL","VHT","LU0942090050.USD","LU0203345920.USD","GLAM","IE0000B7K699.USD","LU0417517546.SGD","LU1037948541.HKD","LU2237443622.USD","IE000MB6IJN5.SGD","SG9999003800.SGD","IE00BDGV0183.EUR","LU0868494617.USD","PJP","ABBV","LU2129689514.USD","IE00BSNM7G36.USD","AGNG","LU0472753341.HKD","SG9999001440.SGD","BK4139","LU0859254822.USD","BK4550","LU1989772923.USD","JDOC","LU0211328371.USD","TRUH","LU0882574055.USD","LU0256863811.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159322769","title":"JPMorgan Unfazed by Rising Rates Impact on China Healthcare, Remains Bullish on Biotech and CXO","url":"https://stock-news.laohu8.com/highlight/detail?id=1159322769","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159322769?lang=en_us&edition=fundamental","pubTime":"2026-10-06 12:00","pubTimestamp":1791259229,"startTime":"0","endTime":"0","summary":"According to a research report released by JPMorgan, as global interest rates, particularly 10-year and 30-year U.S. Treasury yields, climb higher, the risk-free rate used in the bank's DCF models...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","LU2462157665.USD","BK4516","LU2430703178.SGD","LU1116320901.HKD","LU1267930490.SGD","BK4585","LU1366192091.USD","01548","LU2552382132.HKD","LU0196878994.USD","LU2213496289.HKD","IBBJ","LU2505996509.AUD","LU0265550946.USD","LU2045819591.USD","BK1583","LU2357627491.SGD","LU0417516738.SGD","LU1894683348.USD","XBI","IE0034235303.USD","LU1244550221.USD","IE000F7OJYX1.SGD","LU1670628061.USD","LU0256863902.USD","BK4588","LU0310799852.SGD","LU0320765646.SGD","LU0856984785.SGD","LU0943347566.SGD","LU1145028129.USD","LU1720050803.USD","LU2476274720.SGD","LU2756315318.SGD","LU2168563687.JPY","LU1880383366.USD","LU2168564149.EUR","LU2756315664.SGD","LU0267386448.USD","LU0345769631.USD","LU0256863811.USD","SYNB","LU1629891620.HKD","IE00BLSP4452.SGD","LU0029874905.USD","BK1521","LU2746668974.SGD","02359","LU0708995583.HKD","LU0823426480.USD","LU0265550359.USD","IE00B0JY6N72.USD","LU0307460666.USD","LU1366333091.USD","JPO","LU2125910500.SGD","LABU","LU0234570918.USD","LU0868494617.USD","LU2106854487.HKD","LU1496350502.SGD","LU1551013342.USD","IXG","LU2168564222.USD","IE00BFXG1179.USD","LU0211328371.USD","VFH","LU0942090050.USD","LU1551013425.SGD","LU0787776722.HKD","LU3063872942.SGD","LU0211326755.USD","LU0149725797.USD","LU2476274308.USD","IE00BK4W5M84.HKD","LU0211326839.USD","LU2237443895.HKD","LU1917777945.USD","LU1280957306.USD","LU2417539215.USD","CXO","LU1988902786.USD","LU1032466523.USD","HK0000306685.HKD","TFNS","LU0823426308.USD","HK0000320264.USD","IE00BWXC8680.SGD","LU2237443465.HKD","SG9999002463.SGD","LU2430703095.HKD","IE0000B7K699.USD","LU0234572021.USD","LU1668664300.SGD","IE00BBT3K403.USD","LU0157215616.USD","LU2023250330.USD","IE00B1BXHZ80.USD","LU1548497426.USD","LU0043850808.USD","IE00BYXW3230.USD","LU0345770308.USD","LU1244550494.USD","LU2168564495.EUR","SG9999014674.SGD","LU1244550577.SGD","IE000WAW04H5.SGD","EQRR","IE00BJTD4N35.SGD","LU2242649171.HKD","LU2039709279.SGD","IE00BLSP4239.USD","LU0211327993.USD","XLBI","IE00BKDWB100.SGD","LU0320764599.SGD","HK0000320223.HKD","LU2552382215.SGD","KBWB","06990","GDOC","JPMO","LU1064131342.USD","BK4504","LU0976567544.SGD","LU0634319403.HKD","LU0029874061.USD","BK4550","03696","FNCL","LU0323591593.USD","WX","LU0048584097.USD","LU0456846285.SGD","LU0979878070.USD","LU2023250843.SGD","LU0006306889.USD","LU0327786744.USD","LU0820562030.AUD","LU2237443622.USD","LU0588546209.SGD","AGNG","LU0708995153.HKD","LU2488822045.USD","LU1914381329.SGD","LU0463099449.HKD","BK1610","IE000M9KFDE8.USD","KURE","LU0320764243.SGD","LU2552382058.USD","LU1242518931.SGD","LU1496350171.SGD","LU0683600562.USD","LU2237443978.SGD","LU0251132253.USD","LU0326950275.SGD","LU1894683264.USD","UYG","LU2746668461.USD","LU0516423091.SGD","XLF","LU0819121731.USD","LU0052750758.USD","LU0868494708.USD","LU1162221912.USD","LU1720051108.HKD","LU2242644610.SGD","LU2381873111.SGD","HBImain","IE000BZT7R73.USD","BK4534","LU0345770993.USD","LU1188198961.HKD","FTXO","LU1261432733.SGD","LU2237443382.USD","LU0348827113.USD","LU0964807845.USD","IE0034235188.USD","LU0039217434.USD","LU0170899867.USD","LU0516422440.USD","LU0516423174.USD","IE000MB6IJN5.SGD","BK1576","MEDX","LU1119994496.HKD","LU0820561909.HKD","SG9999002232.USD","LU0348767384.USD","LU0345769128.USD","LU2505996681.GBP","LU2244417387.USD","IE0034235295.USD","LU1084165304.USD","LU2168564065.EUR","IXJ","LU1688375341.USD","159760","LU2237443549.SGD","02269","LU0211977185.USD","PEX","BK1141","IE00BDRTCR15.USD","LU0106261372.USD","LU0128526141.USD","BK4533","LU0203347892.USD","TRUF","BK1589","LU0496365809.HKD","LU0689472784.USD","IE00B3S45H60.SGD","IE00BK4W5L77.USD","BK4581","BK4566","LU0561508036.HKD","LU1363072403.SGD","LU2054465674.USD","LU0208291251.USD","LU0859254822.USD","VHT","LU0320765489.SGD","LU0348825331.USD","LU0516422366.SGD","LU2592432038.USD","LU0348766576.USD","LU0211331839.USD","LU0820561818.USD","LU0971096721.USD","SG9999002224.SGD","HK0000306701.USD","IE00BJLML261.HKD","JPM","IE00BKVL7J92.USD","LU2357305700.SGD","IE00BZ1G4Q59.USD","IE00BHPRN162.USD","LU0128522744.USD","LU0882574139.USD","LU2456880835.USD","LU0140636845.USD","IE000SO60NU8.SGD","IYG","LU1046422090.SGD","LU0417516902.SGD","LU0417517546.SGD","LU1670627923.USD","LU0070302665.USD","LU0238689110.USD","LU1974910355.USD","SG9999002562.SGD","LU0181495838.USD","LU0516422952.EUR","LU2430703251.USD","BK4207","LU0187121727.USD","159837","LU0051755006.USD","LU0359201612.USD","LU0640476718.USD","LU1242518857.USD","XLV","LU0106831901.USD","IYF","02268","LU2236285917.USD","LU0215105999.USD","LU1794554557.SGD","LU2778985437.USD","LU0203345920.USD","LU0244354667.USD","IE00B775SV38.USD","LU2023250504.SGD","LU2211815571.USD","BK1161","LU0359202008.SGD","IE00BDCRKT87.USD","LU0456827905.SGD","LU2264538146.SGD","IE00B1XK9C88.USD","LU1116320737.USD","LU0540923850.HKD","IE00BJTD4V19.USD","LU1720051017.SGD","LU0348735423.USD","IEIH","IE00BN8TJ469.HKD","LU0572944931.SGD","LU0469268626.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673035318","title":"Ventas (VTR) Stock Could Be Undervalued Following Its 118% Three Year Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2673035318","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673035318?lang=en_us&edition=fundamental","pubTime":"2026-10-06 09:23","pubTimestamp":1791249802,"startTime":"0","endTime":"0","summary":"Ventas has delivered a powerful long run for shareholders, yet the recent pullback raises a sharper question about whether the current price still lines up with the cash the business is expected to generate. With the spotlight now on its ability to turn its portfolio into steady cash flows, investors are asking how much of that three year journey is already baked into the share price.\n\nOver the past 3 years the stock has gained 118.4%, which puts a lot of weight on whether its future cash...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9621071-choice1-card/1788952821088","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9621071-choice1-card/1788952821088"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-vtr/ventas/news/ventas-vtr-stock-could-be-undervalued-following-its-118-thre","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-vtr/ventas/news/ventas-vtr-stock-could-be-undervalued-following-its-118-thre","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","HAUS","DCF","REZ","SRHR","RSPR","VTR","AGNG","JPRE","BK4585","BK4203","BK4225","BYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149473479","title":"Tianjin Unveils Sweeping Plan to Reshape Elderly Care and Senior Services for the Next Five Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1149473479","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149473479?lang=en_us&edition=fundamental","pubTime":"2026-10-06 06:51","pubTimestamp":1791240670,"startTime":"0","endTime":"0","summary":"The \"Tianjin 15th Five-Year Plan for the Development of Elderly Affairs and the Construction of the Elderly Care Service System\" has been issued.By the end of 2025, the city's resident population...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","HLGE","YUNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084496","title":"Edwards Lifesciences Corp. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084496","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084496?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:51","pubTimestamp":1791233460,"startTime":"0","endTime":"0","summary":"DJ Edwards Lifesciences Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Edwards Lifesciences Corp.  advanced 2.44% to $87.23 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.66% to 7,773.95 and the Dow Jones Industrial Average  rising 0.18% to 51,267.90.The stock's rise snapped a three-day losing streak.Edwards Lifesciences Corp. closed 9.41% below its 52-week high of $96.29, which the company achieved on July 7th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Abbott Laboratories  rose 2.67% to $100.10, Medtronic PLC  rose 1.84% to $87.97, and Stryker Corp.  rose 3.55% to $285.22.Trading volume  remained 339,452 below its 50-day average volume of 3.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765489.SGD","SGXZ23171101.USD","LU0158827948.USD","LU2324357040.USD","LU1670628061.USD","SYK","GB00B4LPDJ14.GBP","SGXZ41872573.SGD","LU2089984988.USD","SG9999004303.SGD","LU2506951958.HKD","IHI","LU0266013472.USD","IE00BFTCPJ56.SGD","EW","LU0690374961.EUR","LU1989763690.USD","BMED","LU2112291526.USD","MDT","BK4585","LU1791710400.SGD","ABT","LU0070302665.USD","BK4581","LU1691799644.USD","LU2028103732.USD","IE00B4R5TH58.HKD","LU2362541513.USD","LU2468319806.SGD","IE00BVYPNV92.GBP","LU0072461881.USD","IE00BGHQF631.EUR","LU0211331839.USD","PJP","LU0170899867.USD","IE00BN0W2W23.USD","LU0528227936.USD","IE00BQXX3F31.USD","IE00BDGV0183.EUR","AGNG","LU1291159041.SGD","GB00B4QBRK32.GBP","IE00B42XCP33.USD","LU0234572021.USD","LU2506951875.HKD","LU2404859667.USD","TMED","BK4504","LU0976567544.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084323","title":"AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084323","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084323?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:31","pubTimestamp":1791232260,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  advanced 1.12% to $265.76 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.66% to 7,773.95 and the Dow Jones Industrial Average  rising 0.18% to 51,267.90.This was the stock's second consecutive day of gains.AbbVie Inc. closed 1.35% short of its 52-week high of $269.39, which the company achieved on September 23rd.The stock outperformed some of its competitors Monday, as Johnson & Johnson  fell 1.21% to $252.93, Pfizer Inc.  fell 1.40% to $27.41, and Amgen Inc.  fell 0.01% to $402.98.Trading volume  eclipsed its 50-day average volume of 4.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1236620834.HKD","LU2347655156.SGD","LU0124676726.USD","LU0211327993.USD","LU0965509010.AUD","LU2237443382.USD","JDOC","LU0795875086.SGD","PPH","FHLC","LU1267930490.SGD","LU0256863811.USD","LU1732799900.SGD","FTXH","LU2089283258.USD","LU0861579265.USD","LU1291159041.SGD","LU2129689605.HKD","LU0965508806.USD","BK4581","IE000F7OJYX1.SGD","LU0661504455.SGD","LU1430594728.SGD","LU0726765562.USD","IE00B3PB1722.GBP","IE00B19Z3581.USD","LU2087621335.USD","LU0395794307.EUR","IE0000B7K699.USD","LU2023251221.USD","IE00BN8TJ469.HKD","LU1003077747.HKD","LU1244550494.USD","IE00B19Z3B42.SGD","LU0114720955.EUR","LU2237443549.SGD","IE0002141913.USD","LU0820561909.HKD","LU2129689514.USD","LU0965509101.SGD","IE0009355771.USD","LU1839511570.USD","LU1093756168.USD","IE00BSNM7G36.USD","BK4588","LU0859254822.USD","LU0320765646.SGD","LU1585245621.USD","LU0122379950.USD","LU0689626769.HKD","LU2357627491.SGD","BK4533","IE00BJJMRZ35.SGD","LU0029864427.USD","LU2125909247.SGD","LU0198837287.USD","LU1057294990.SGD","LU1267930573.SGD","ABBV","IE00BFTCPJ56.SGD","LU0708994859.HKD","AGNG","LU0170899867.USD","LU0289739343.SGD","RXL","SG9999015986.USD","LU0310800379.SGD","LU1934455277.USD","LU1929549753.HKD","LU0472753341.HKD","LU2433249047.HKD","LU2112291526.USD","IE00BLSP4452.SGD","LU1732800096.USD","IE00B42XCP33.USD","LU2237443978.SGD","LU0985320562.USD","LU0882574055.USD","LU2089984988.USD","GLAM","BK4550","IE00B2B36J28.USD","LU1037948541.HKD","LU0234572021.USD","IE0002270589.USD","LU1670627923.USD","LU0868494617.USD","LU0942090050.USD","LU1023059063.AUD","LU1923622614.USD","LU1162221912.USD","LU0545039389.USD","SG9999001440.SGD","LU1989772840.SGD","LU0738911758.USD","LU1093756325.SGD","LU1720051108.HKD","MEDX","LU2237443895.HKD","LU1989772923.USD","LU0234570918.USD","LU0912757837.SGD","LU0256863902.USD","LU1551013425.SGD","LU1670628061.USD","PJP","LU1718418525.SGD","LU2133065610.SGD","IE000WAW04H5.SGD","LU0820561818.USD","LU0310799852.SGD","LU0965509283.SGD","LU0511384066.AUD","IE00BVYPNW00.USD","LU1061106388.HKD","LU0417517546.SGD","LU2237443622.USD","LU2237443465.HKD","LU1720051017.SGD","LU0128525929.USD","SG9999015952.SGD","XLV","LU0456855351.SGD","VHT","BK4534","IE000BZT7R73.USD","LU0949170772.SGD","LU1496350502.SGD","LU1934455863.HKD","LU1548497426.USD","IE00BGHQF631.EUR","LU0158827948.USD","LU0289739699.SGD","LU0211328371.USD","LU0943347566.SGD","LU1244550577.SGD","LU1551013342.USD","IE000SO60NU8.SGD","LU0289961442.SGD","LU0203347892.USD","IE00BLSP4239.USD","IE00BBT3K403.USD","LU0689472784.USD","SG9999015945.SGD","LU1983299246.USD","LU2468319806.SGD","LU0823416689.USD","LU1244550221.USD","BK4585","LU2357305700.SGD","IE00BDGV0183.EUR","LU0069063385.USD","LU1989771016.USD","SG9999011175.SGD","LU0203345920.USD","LU0057025933.USD","LU1934455194.USD","LU2125909593.SGD","BK4566","IE000MB6IJN5.SGD","IE00B4R5TH58.HKD","IYH","SG9999003800.SGD","LU0432979614.USD","LU0868494708.USD","LU1496350171.SGD","LU1037948897.HKD","LU0795875169.SGD","LU2347655073.USD","LU1074936037.SGD","IE00BJT1NW94.SGD","LU0058720904.USD","IE00BVYPNV92.GBP","LU1236620750.USD","BK4559","TRUH","LU0098860793.USD","LU2089284900.SGD","BK4139","SG9999015978.USD","IE0004445239.USD","IXJ","LU2129689431.USD","LU0553294199.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081209","title":"AbbVie Cuts Q3 Adjusted Diluted EPS Outlook to $3.73-$3.77 After $216 Million Acquired Ipr&d, Milestones Expense","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081209","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081209?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:09","pubTimestamp":1791230948,"startTime":"0","endTime":"0","summary":"AbbVie cuts Q3 adjusted diluted EPS outlook to $3.73-$3.77 after $216 million acquired IPR&D, milestones expenseAbbVie cut Q3 2026 adjusted diluted EPS guidance to USD 3.73–3.77 from USD 3.84–3.88, re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDLbW9K2t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","SG9999015978.USD","BK4550","GLAM","IE000SO60NU8.SGD","LU1236620750.USD","FHLC","IYH","LU0122379950.USD","LU0943347566.SGD","LU0553294199.USD","LU1934455863.HKD","LU0320765646.SGD","BK4588","FTXH","LU0170899867.USD","BK4534","LU1732799900.SGD","LU2023251221.USD","IE00B3PB1722.GBP","LU1037948541.HKD","MEDX","LU1720051108.HKD","LU1585245621.USD","LU0158827948.USD","LU1430594728.SGD","LU1023059063.AUD","XLV","ABBV","LU1162221912.USD","LU0661504455.SGD","LU1236620834.HKD","LU1267930573.SGD","IE0002141913.USD","IE0004445239.USD","JDOC","IXJ","TRUH","IE000BZT7R73.USD","LU0203345920.USD","PPH","RXL","IE00BGHQF631.EUR","PJP","VHT","LU2237443978.SGD","AGNG","IE00BDGV0183.EUR","LU0234570918.USD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673812780","title":"Abbvie - Full-Year 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $13.76-$13.96 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673812780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673812780?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2023251221.USD","BK4534","LU1585245621.USD","LU0122379950.USD","BK4550","LU1267930573.SGD","JDOC","SG9999015978.USD","IXJ","MEDX","LU1934455863.HKD","RXL","ABBV","IE00B3PB1722.GBP","IE00BDGV0183.EUR","BK4566","LU0170899867.USD","LU1162221912.USD","LU1732799900.SGD","LU2237443978.SGD","TRUH","IYH","IE000BZT7R73.USD","AGNG","LU0128525929.USD","BK4588","XLV","LU1037948541.HKD","IE0004445239.USD","PPH","PJP","LU0661504455.SGD","IE0002141913.USD","IE00BGHQF631.EUR","FTXH","LU1720051108.HKD","LU0158827948.USD","FHLC","LU0320765646.SGD","LU1023059063.AUD","LU0553294199.USD","VHT","LU1236620750.USD","LU0943347566.SGD","LU0234570918.USD","LU1236620834.HKD","LU0203345920.USD","LU1430594728.SGD","IE000SO60NU8.SGD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673220081","title":"Abbvie - Q3 2026 Gaap and Adj Earnings Include $216 Mln Bought Ipr&D and Milestones Expense - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673220081","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673220081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0211327993.USD","LU0738911758.USD","LU1585245621.USD","BK4139","JDOC","LU1720051017.SGD","PPH","IXJ","LU0708994859.HKD","LU1551013425.SGD","LU0689626769.HKD","IE00BGHQF631.EUR","LU2087621335.USD","AGNG","XLV","MEDX","LU1267930573.SGD","LU0114720955.EUR","PJP","GLAM","LU0795875169.SGD","LU0912757837.SGD","LU1496350502.SGD","IYH","TRUH","LU2237443978.SGD","LU0823416689.USD","FHLC","LU2129689431.USD","LU0795875086.SGD","LU0124676726.USD","LU0417517546.SGD","LU2237443895.HKD","BK4581","LU0058720904.USD","IE00BSNM7G36.USD","FTXH","LU0158827948.USD","LU2357305700.SGD","LU0545039389.USD","LU0553294199.USD","LU1061106388.HKD","BK4534","LU0661504455.SGD","LU1003077747.HKD","LU1244550577.SGD","RXL","VHT","LU0203347892.USD","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081273","title":"Abbvie Inc. Fy2026 Shr View $14.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081273?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FTXH","MEDX","LU1003077747.HKD","LU0943347566.SGD","FHLC","PJP","ABBV","LU0122379950.USD","LU1983299246.USD","LU1732799900.SGD","IE00BJT1NW94.SGD","LU1720051108.HKD","LU0965509010.AUD","IE00B3PB1722.GBP","AGNG","GLAM","LU1061106388.HKD","LU0738911758.USD","LU1923622614.USD","BK4581","JDOC","LU2125909593.SGD","LU0417517546.SGD","LU1989772923.USD","LU2237443465.HKD","LU1057294990.SGD","SG9999003800.SGD","LU0098860793.USD","LU2125909247.SGD","LU2237443549.SGD","RXL","IXJ","LU1718418525.SGD","SG9999015952.SGD","LU0203345920.USD","TRUH","LU0058720904.USD","VHT","IYH","LU0256863902.USD","LU1267930573.SGD","LU2237443622.USD","LU1093756168.USD","PPH","XLV","LU2347655073.USD","LU0859254822.USD","LU0057025933.USD","SG9999015978.USD","IE0004445239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081227","title":"Abbvie - Q3 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $3.73-$3.77 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081227","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081227?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2347655073.USD","IE00BN8TJ469.HKD","JDOC","LU1839511570.USD","PPH","LU2112291526.USD","IXJ","LU1934455194.USD","LU1023059063.AUD","LU1718418525.SGD","LU0949170772.SGD","AGNG","XLV","IE00B3PB1722.GBP","MEDX","PJP","GLAM","LU0256863811.USD","LU1244550221.USD","LU1496350502.SGD","IYH","LU2125909593.SGD","TRUH","FHLC","LU0395794307.EUR","LU0170899867.USD","LU2237443465.HKD","IE00BLSP4452.SGD","LU2237443622.USD","BK4581","LU0058720904.USD","FTXH","LU0511384066.AUD","LU0472753341.HKD","LU2237443382.USD","LU1236620750.USD","LU0289961442.SGD","SG9999001440.SGD","BK4534","LU0861579265.USD","LU2089283258.USD","LU1929549753.HKD","RXL","SG9999015945.SGD","VHT","LU1037948897.HKD","IE00B19Z3B42.SGD","ABBV","LU0689472784.USD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673819760","title":"Genmab, AbbVie Say New Drug Combo Helps Lymphoma Patients Stay Cancer-Free Longer","url":"https://stock-news.laohu8.com/highlight/detail?id=2673819760","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673819760?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:50","pubTimestamp":1791229824,"startTime":"0","endTime":"0","summary":"Genmab  and AbbVie  said that adding their drug epcoritamab to a standard chemotherapy mix helped people with an aggressive form of blood cancer stay cancer-free longer than chemotherapy alone.The combination cut the risk of the cancer getting worse or the patient dying by 51% compared with standard treatment alone, the companies said Monday in a statement. Results were from a large study in newly diagnosed patients with diffuse large B-cell lymphoma, the most common type of non-Hodgkin lymphoma.The treatment paired epcoritamab with R-CHOP, a long-used chemotherapy regimen. The companies said the safety of the combination looked generally similar to what doctors already expect from each drug on its own.Because the treatment is still experimental, Genmab and AbbVie plan to meet with regulators around the world to discuss next steps.Genmab shares rose 11% in Monday trading, and AbbVie gained 1.3%.Price: 38.72, Change: +3.97, Percent Change: +11.41","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128525929.USD","LU0942090050.USD","LU0965509101.SGD","LU1244550221.USD","LU1839511570.USD","IE00BLSP4239.USD","IYH","LU1989772840.SGD","LU2347655156.SGD","LU0689626769.HKD","LU2125909593.SGD","GMAB","JDOC","FHLC","ABBV","RXL","IE00BSNM7G36.USD","LU2129689605.HKD","PPH","TRUH","IE000MB6IJN5.SGD","XLV","LU0158827948.USD","LU1162221912.USD","BK4581","IE00BVYPNW00.USD","IE00BN8TJ469.HKD","SG9999003800.SGD","LU2237443549.SGD","GLAM","MEDX","IXJ","LU0795875169.SGD","LU2089284900.SGD","LU0256863811.USD","PJP","LU1983299246.USD","LU0395794307.EUR","IE00B4R5TH58.HKD","LU2089283258.USD","LU1057294990.SGD","LU2237443382.USD","LU2347655073.USD","VHT","LU1923622614.USD","LU2237443465.HKD","LU0859254822.USD","FTXH","SG9999015945.SGD","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673811030","title":"Genmab and AbbVie Report Landmark Phase 3 Win for Epcoritamab Combo in Frontline DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2673811030","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673811030?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:47","pubTimestamp":1791229638,"startTime":"0","endTime":"0","summary":"An announcement from Genmab ( ($GMAB) ) is now available. Genmab and AbbVie reported on October 5, 2026, that their Phase 3 EPCORE DLBCL-2 trial sh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genmab-and-abbvie-report-landmark-phase-3-win-for-epcoritamab-combo-in-frontline-dlbcl?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genmab-and-abbvie-report-landmark-phase-3-win-for-epcoritamab-combo-in-frontline-dlbcl?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU1236620750.USD","AGNG","LU0158827948.USD","MEDX","FTXH","LU2468319806.SGD","LU1037948541.HKD","IE00BDGV0183.EUR","LU1037948897.HKD","TRUH","IE000SO60NU8.SGD","BK4581","LU1929549753.HKD","ABBV","VHT","LU1670628061.USD","BK4585","LU0965509283.SGD","LU0689626769.HKD","FHLC","LU2357305700.SGD","LU0122379950.USD","IE000F7OJYX1.SGD","IE00B4R5TH58.HKD","LU1551013342.USD","RXL","LU1718418525.SGD","XLV","IXJ","LU1074936037.SGD","LU2089284900.SGD","BK4550","BK4559","JDOC","GLAM","IE00B3PB1722.GBP","LU2237443465.HKD","IYH","LU2237443382.USD","LU0823416689.USD","PJP","LU1496350502.SGD","LU0289739699.SGD","LU1720051017.SGD","PPH","LU2237443978.SGD","LU0965509101.SGD","LU1244550221.USD","LU0456855351.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673363081","title":"AbbVie Blood Cancer Drug Combo Cuts Risk of Progression or Death in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2673363081","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673363081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:36","pubTimestamp":1791228977,"startTime":"0","endTime":"0","summary":"AbbVie blood cancer drug combo cuts risk of progression or death in late-stage studyOct 5 (Reuters)-Danish biotech firm GenmabGMAB.COand US drugmaker AbbVieABBV.Nsaid on Monday their combination treat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nL4N45R185:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","LU1983299246.USD","AGNG","RXL","LU2347655156.SGD","LU1244550221.USD","LU2237443382.USD","PPH","JDOC","FHLC","LU0256863811.USD","FTXH","LU2089283258.USD","LU2125909593.SGD","PJP","LU2129689605.HKD","BK4581","IE000MB6IJN5.SGD","IE00B4R5TH58.HKD","IYH","IE00BVYPNW00.USD","LU0395794307.EUR","SG9999003800.SGD","IE00BN8TJ469.HKD","LU0795875169.SGD","LU2237443465.HKD","LU2237443549.SGD","LU2347655073.USD","GLAM","LU0128525929.USD","XLV","LU0965509101.SGD","LU1839511570.USD","VHT","IE00BSNM7G36.USD","LU0859254822.USD","LU0942090050.USD","LU0689626769.HKD","LU0158827948.USD","LU1923622614.USD","LU2089284900.SGD","TRUH","LU1162221912.USD","LU1989772840.SGD","LU1057294990.SGD","ABBV","IE00BFTCPJ56.SGD","IE00BLSP4239.USD","IXJ","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673311081","title":"Genmab, AbbVie report epcoritamab combination demonstrates improved PFS in study","url":"https://stock-news.laohu8.com/highlight/detail?id=2673311081","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673311081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:55","pubTimestamp":1791226515,"startTime":"0","endTime":"0","summary":"Genmab A/S (GMAB) and AbbVie (ABBV) announced “positive” topline results from the Phase 3 EPCORE DLBCL-2 trial evaluating fixed treatment duration ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genmab-abbvie-report-epcoritamab-combination-demonstrates-improved-pfs-in-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genmab-abbvie-report-epcoritamab-combination-demonstrates-improved-pfs-in-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128525929.USD","LU1551013342.USD","LU2433249047.HKD","LU0456855351.SGD","TRUH","LU2089284900.SGD","LU1934455194.USD","GMAB","AGNG","LU1074936037.SGD","RXL","LU1267930490.SGD","LU0511384066.AUD","VHT","SG9999001440.SGD","FTXH","LU0395794307.EUR","LU0726765562.USD","IYH","LU0289739699.SGD","LU0211328371.USD","IXJ","LU0868494617.USD","LU1585245621.USD","LU2087621335.USD","LU0203345920.USD","LU0256863902.USD","MEDX","LU0058720904.USD","LU1720051108.HKD","LU2023251221.USD","PJP","SG9999015986.USD","LU2357627491.SGD","IE00BJT1NW94.SGD","PPH","IE000MB6IJN5.SGD","LU1496350171.SGD","LU0069063385.USD","LU0057025933.USD","LU2125909593.SGD","FHLC","GLAM","LU0417517546.SGD","LU1023059063.AUD","LU1934455277.USD","LVIG","XLV","JDOC","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673089429","title":"Genmab Says Phase 3 Epcore DLBCL-2 Trial Shows Epcoritamab Plus R-CHOP Cuts Progression or Death Risk 51% in Newly Diagnosed DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2673089429","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673089429?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:50","pubTimestamp":1791226259,"startTime":"0","endTime":"0","summary":"Genmab says Phase 3 EPCORE DLBCL-2 trial shows epcoritamab plus R-CHOP cuts progression or death risk 51% in newly diagnosed DLBCLGenmab, AbbVie reported positive topline Phase 3 results for epcoritam","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDLWBPbl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","IE00B19Z3B42.SGD","LU1585245621.USD","AGNG","LU0320765646.SGD","LU2468319806.SGD","IE000SO60NU8.SGD","IE000WAW04H5.SGD","FHLC","IE00BKPKM429.USD","LU0310799852.SGD","IE00BJT1NW94.SGD","BK4550","FTXH","XLV","LU2095319765.USD","LU0234570918.USD","TRUH","BCDF","LU0158827948.USD","ABBV","BK4581","IE00BN0W2V16.EUR","LU0289961442.SGD","LU0912757837.SGD","PJP","JDOC","LU1720051017.SGD","MEDX","IE00B2B36J28.USD","LU0114720955.EUR","LU0859254822.USD","IE00B19Z3581.USD","RXL","IXJ","IE00BQXX3F31.USD","LU1003077747.HKD","PPH","IYH","VHT","LU0198837287.USD","LU0943347566.SGD","IE00BGHQF748.EUR","LU1923622614.USD","LU0882574055.USD","BK4588","LU1989771016.USD","NDAQ","LU2089283258.USD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673894940","title":"Genmab - Phase 3 Trial Shows 51% Reduction in Risk of Progression or Death in Dlbcl","url":"https://stock-news.laohu8.com/highlight/detail?id=2673894940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673894940?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:49","pubTimestamp":1791226144,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1GV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","IE00B19Z3B42.SGD","LU0456855351.SGD","LU1585245621.USD","AGNG","LU0320765646.SGD","LU2468319806.SGD","IE000SO60NU8.SGD","IE000WAW04H5.SGD","FHLC","LU0310799852.SGD","IE00BJT1NW94.SGD","BK4550","LU1551013425.SGD","FTXH","XLV","LU0234570918.USD","TRUH","LU0158827948.USD","ABBV","BK4581","LU0289961442.SGD","LU0912757837.SGD","IE0000B7K699.USD","PJP","JDOC","LU1720051017.SGD","MEDX","IE00BBT3K403.USD","IE00B2B36J28.USD","LU0114720955.EUR","LU0859254822.USD","IE00B19Z3581.USD","RXL","LU0965509010.AUD","IXJ","LU1003077747.HKD","PPH","IYH","VHT","LU0198837287.USD","LU0943347566.SGD","LU1923622614.USD","LU0882574055.USD","BK4588","LU1267930573.SGD","LU0553294199.USD","LU1989771016.USD","LU2089283258.USD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673894110","title":"Genmab: Safety Profile of Epcoritamab When Administered in Combination with Standard of Care R-Chop was Generally Well Tolerated","url":"https://stock-news.laohu8.com/highlight/detail?id=2673894110","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673894110?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:49","pubTimestamp":1791226144,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1GV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0965509101.SGD","LU2023251221.USD","LU0738911758.USD","IE0004445239.USD","LU1244550577.SGD","BK4566","JDOC","LU1551013425.SGD","IE00BJJMRZ35.SGD","PPH","LU0795875086.SGD","LU0256863811.USD","LU2237443382.USD","TRUH","LU1548497426.USD","MEDX","RXL","BK4559","GLAM","LU0861579265.USD","ABBV","LU0128525929.USD","PJP","IE00BVYPNV92.GBP","LU0417517546.SGD","LU0708994859.HKD","LU1037948541.HKD","FTXH","XLV","IYH","LU2357627491.SGD","AGNG","FHLC","LU0456855351.SGD","LU0795875169.SGD","SG9999015952.SGD","VHT","BK4534","LU0868494617.USD","LU2129689605.HKD","LU0256863902.USD","LU0234570918.USD","IE00BJT1NW94.SGD","LU0689626769.HKD","BK4550","LU1934455194.USD","LU1989772923.USD","LU1934455277.USD","IXJ","LU0949170772.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673089491","title":"Genmab and Abbvie Announce Epcoritamab in Combination with R-Chop Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2673089491","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673089491?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:49","pubTimestamp":1791226144,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1GV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1551013342.USD","IE00B3PB1722.GBP","LU0689472784.USD","LU1934455277.USD","LU2087621335.USD","LU2089984988.USD","VHT","BK4585","IYH","LU1934455863.HKD","RXL","ABBV","LU0820561909.HKD","FHLC","TRUH","LU1267930490.SGD","GLAM","LU1236620750.USD","IE000SO60NU8.SGD","LU2112291526.USD","MEDX","LU0320765646.SGD","LU1037948897.HKD","LU2237443382.USD","IE00B19Z3B42.SGD","LU0868494617.USD","LU0965509101.SGD","LU1989772840.SGD","FTXH","IE000BZT7R73.USD","LU0823416689.USD","LU1923622614.USD","PJP","LU1720051108.HKD","LU0511384066.AUD","XLV","LU1267930573.SGD","JDOC","LU0868494708.USD","LU1585245621.USD","IXJ","LU2433249047.HKD","IE00BVYPNW00.USD","LU2089284900.SGD","AGNG","PPH","LU1023059063.AUD","LU2129689605.HKD","LU2129689514.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673408917","title":"Eli Lilly Stock (LLY) Gains on Regulatory Win for Experimental Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2673408917","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673408917?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:35","pubTimestamp":1791225314,"startTime":"0","endTime":"0","summary":"The stock of Eli Lilly ($LLY) is up about 1% on Oct. 5 after the company secured a regulatory win for one of its experimental cancer drugs called O...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-stock-lly-gains-on-regulatory-win-for-experimental-cancer-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-stock-lly-gains-on-regulatory-win-for-experimental-cancer-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999014898.SGD","LU0323591593.USD","LU2491049909.HKD","LU2746668461.USD","LU2491050071.SGD","LU0823434583.USD","LU2237443382.USD","PPH","LU1629891620.HKD","JDOC","FHLC","LU1917777945.USD","LU0823434740.USD","LU0354030511.USD","LU2265009873.SGD","LU0256863811.USD","FTXH","IE00BJLML261.HKD","LU0079474960.USD","LU2089283258.USD","LU2324357040.USD","LU2750360997.AUD","SG9999017495.SGD","LU1291159041.SGD","IE00B1BXHZ80.USD","LU0786609619.USD","BK4581","LU1712237335.SGD","LU0061475181.USD","LU2361044865.SGD","LU2361045086.USD","LU0203202063.USD","SG9999014880.SGD","LU2361044949.HKD","LU2023251221.USD","SGXZ51526630.SGD","LU2237443549.SGD","LU0114720955.EUR","LU0353189763.USD","SG9999014906.USD","SGXZ99366536.SGD","IE0002141913.USD","LLY","LU0820561909.HKD","LU0964807845.USD","IE0009355771.USD","IE00B775H168.HKD","LU2552382215.SGD","LU1093756168.USD","LU0640476718.USD","IE00BJJMRX11.SGD","IE00BKDWB100.SGD","BK4588","LU0354030438.USD","SGXZ31699556.SGD","LU0122379950.USD","LU0096364046.USD","LU0210536198.USD","LU2106854487.HKD","BK4533","IE00BJJMRZ35.SGD","LU2168564065.EUR","BK4007","LU0820562030.AUD","LU0466842654.USD","LU2552382058.USD","IE00BK4W5M84.HKD","LU0198837287.USD","LU1057294990.SGD","LU2168564222.USD","IE00BFTCPJ56.SGD","LU0203201768.USD","LU0316494557.USD","LU0471298694.HKD","LU2168564495.EUR","LU2271345857.HKD","LU1127390331.HKD","AGNG","LU0385154629.USD","RXL","IE0005OL40V9.USD","LU0708995401.HKD","LU0094547139.USD","LU2756315664.SGD","LU2471134796.USD","SG9999015986.USD","LU0225283273.USD","LU0320765059.SGD","LU1814569148.SGD","LU1868837136.USD","THNR","LU2112291526.USD","OZEM","GB00BDT5M118.USD","LU1069344957.HKD","LU2471134523.USD","SG9999018857.SGD","LU2213496289.HKD","LU1868836591.USD","LU2237443978.SGD","LU2028103732.USD","LU0882574055.USD","LU2089984988.USD","LU2456880835.USD","LU2417539215.USD","IE00B2B36J28.USD","LU0234572021.USD","SGXZ57979304.SGD","LU0787776722.HKD","MHIP","LU1023059063.AUD","LLYX","IE00BWXC8680.SGD","LU0109394709.USD","LU0672654240.SGD","LU2087625088.SGD","LU0158827781.USD","LU2237438978.USD","LU0109391861.USD","LU1691799644.USD","SG9999014914.USD","LU1093756325.SGD","LU1720051108.HKD","SG9999001176.SGD","LU2896262040.SGD","IE00BFSS7M15.SGD","MEDX","LU2168564149.EUR","LU1323610961.USD","LU2237443895.HKD","WDNA","ELIS","LU2462591350.SGD","BK4599","SG9999018865.SGD","LU0256863902.USD","LU1551013425.SGD","LU2108987350.USD","LU2756315318.SGD","LU0238689110.USD","LU0345770308.USD","LU2211815571.USD","PJP","LU2462157665.USD","LU0320765992.SGD","LU0345770993.USD","LU1366192091.USD","LU2750360641.GBP","SGXZ81514606.USD","LU0820561818.USD","LLII","LU1061106388.HKD","LU1145028129.USD","LU2111349929.HKD","IE00BFSS8Q28.SGD","LU0417517546.SGD","LU2237443622.USD","LU2237443465.HKD","LU1720051017.SGD","LU1974910355.USD","IE00BKPKM429.USD","LU2491050154.USD","LU2552382132.HKD","SG9999015952.SGD","LU2746668974.SGD","LU0456855351.SGD","LU0106261372.USD","LU2063271972.USD","VHT","XLV","BK4534","LU2023250330.USD","LU1979441026.SGD","LU1548497426.USD","LU0289739699.SGD","LU0158827948.USD","HRTS","LU0943347566.SGD","LU1551013342.USD","LU0174119429.USD","LU0006306889.USD","IE00B4JS1V06.HKD","SG9999013999.USD","LU0689472784.USD","SG9999015945.SGD","SG9999001176.USD","CANC","IE0001KFT4U8.USD","IE00BJJMRY28.SGD","LU1983299246.USD","LU2468319806.SGD","LLYZ","LU0823416689.USD","LU1064131342.USD","LU1623119135.USD","IE00B7KXQ091.USD","TMED","BK4585","LU2357305700.SGD","LU1267930730.SGD","LU0471298777.SGD","LU2360106947.USD","LU1232071149.USD","LU1868836757.USD","LU1989771016.USD","LU2023250504.SGD","IHE","LU2264538146.SGD","ILDR","LU1280957306.USD","LU0882574139.USD","LU2471134952.CNY","LU2236285917.USD","GDOC","IE00B4R5TH58.HKD","IYH","LU0266013472.USD","LU0889565916.HKD","IE00B1XK9C88.USD","IE00BK4W5L77.USD","LU0432979614.USD","BK4516","LU1035775433.USD","IE00BN29S564.USD","LU1804176565.USD","LU0097036916.USD","MEDI","CURE","IE00BJT1NW94.SGD","LU0058720904.USD","LU2168563687.JPY","IE0004445015.USD","LU1988902786.USD","LU2602419157.SGD","LU1868836914.USD","LU0683600562.USD","LU2471134879.HKD","ELIL","TRUH","LU2089284900.SGD","LU2461242641.AUD","LU0133085943.USD","LU0353189680.USD","SG9999015978.USD","IE0004445239.USD","IXJ","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":4,"totalSize":217,"code":"91000000","status":"200"}]}}